Kymera Therapeutics, Inc. (KYMR)
NASDAQ·Healthcare·Biotechnology
$131.50
-0.46%
Mkt Cap $11.25B
Analyst Ratings
Buy
18
Hold
0
Sell
0
Price Target (72 analysts)
$138.07
Range $97.00 – $180.00
Implied Upside
+5.0%
Consensus $138.07 vs current $131.50
NASDAQ·Healthcare·Biotechnology
$131.50
-0.46%
Mkt Cap $11.25B
Buy
18
Hold
0
Sell
0
Price Target (72 analysts)
$138.07
Range $97.00 – $180.00
+5.0%
Consensus $138.07 vs current $131.50